Emerging and High Growth Companies

BioRender in Dimension Capital’s investment at a $900-million valuation BioRender in Dimension Capital’s investment at a $900-million valuation

BioRender
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Gary Marshall

Partner, Emerging and High Growth Companies, Toronto

Sahil Chopra

Associate, Emerging and High Growth Companies, Toronto

On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900-million valuation.

BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes.

Osler, Hoskin & Harcourt LLP advised BioRender with a team consisting of Chad Bayne, Gary Marshall and Sahil Chopra (Emerging and High Growth Companies).

Value
$900 million
Date Announced
December 18, 2025
Lead Office
Toronto
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Gary Marshall

Partner, Emerging and High Growth Companies, Toronto

Sahil Chopra

Associate, Emerging and High Growth Companies, Toronto